National Institute of General Medical Sciences; Notice of Meeting, 47857-47858 [2012-19695]
Download as PDF
<![CDATA[
47857
Federal Register / Vol. 77, No. 155 / Friday, August 10, 2012 / Notices
Instrument: A summary of the progress on the following
activities
Number of
respondents
Responses
per
respondent
Total
responses
Hours per
response
Total burden
hours
Organizational Information ...................................................
33
1
33
2
66
Total ..............................................................................
33
1
33
........................
1,452
Written comments and
recommendations concerning the
proposed information collection should
be sent within 30 days of this notice to
the desk officer for HRSA, either by
email to OIRA_submission@omb.eop.
gov or by fax to 202–395–5806. Please
direct all correspondence to the
‘‘attention of the desk officer for HRSA.’’
Dated: August 6, 2012.
Wendy Ponton,
Director, Office of Management.
[FR Doc. 2012–19653 Filed 8–9–12; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Secretary’s Advisory Committee on
Heritable Disorders in Newborns and
Children; Notice of Meeting
mstockstill on DSK4VPTVN1PROD with NOTICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463, codified at 5 U.S.C.
App. 2), notice is hereby given of the
following meeting:
Name: Secretary’s Advisory Committee on
Heritable Disorders in Newborns and
Children.
Dates and Times: September 13, 2012, 8:30
a.m. to 6:00 p.m., September 14, 2012, 8:30
a.m. to 2:30 p.m.
Place: Hubert H. Humphrey Building, 200
Independence Avenue SW., Room 800,
Washington, DC 20201.
Status: The meeting is open to the public,
but seating will be limited by the space
available. Security at the Humphrey building
has requested that the public register for the
meeting by September 11, 2012. See https://
www.hrsa.gov/advisorycommittees/mchb
advisory/heritabledisorders for a link to
register for the meeting. Please have a
government I.D. for the meeting. For
directions to the meeting, please visit
https://www.hhs.gov/about/hhhmap.html.
Purpose: The Secretary’s Advisory
Committee on Heritable Disorders in
Newborns and Children (SACHDNC), as
authorized by Public Law 106–310, which
added section 1111 of the Public Health
Service Act, codified at 42 U.S.C. 300b–10,
was established by Congress to advise the
Secretary of the Department of Health and
Human Services with the development of
newborn screening activities, technologies,
policies, guidelines, and programs for
effectively reducing morbidity and mortality
VerDate Mar<15>2010
18:02 Aug 09, 2012
Jkt 226001
in newborns and children having, or at risk
for, heritable disorders. The SACHDNC’s
recommendations regarding additional
conditions/inherited disorders for screening
that have been adopted by the Secretary are
included in the Recommended Uniform
Screening Panel (RUSP) that constitutes part
of the comprehensive guidelines supported
by the Health Resources and Services
Administration. Pursuant to section 2713 of
the Public Health Service Act, codified at 42
U.S.C. 300gg–13, non-grandfathered health
plans are required to cover screenings
included in the comprehensive guidelines
without charging a co-payment, co-insurance,
or deductible for plan years (i.e., policy
years) beginning on or after the date that is
one year from the Secretary’s adoption of the
screening. The SACHDNC also provides
advice and recommendations concerning
grants and projects authorized under section
1109 of the Public Health Service Act (42
U.S.C. 300b–8).
Agenda: The meeting will include: (1)
Updates on newborn screening case
definitions and newborn screening quality
indicators; (2) updates from the Nomination
and Prioritization Workgroup and the
Condition Review Workgroup regarding the
final condition review matrix,
Adrenoleukodystrophy, and Pompe Disease;
(3) presentations on the National Institutes
for Health’s Ethical, Legal, and Social
Implications Research Program, HRSAfunded prenatal family history project, and
the Institute of Medicine meeting summary
on assessing the economics of genomic
medicine; (4) reports on the continued work
of the Advisory Committee’s subcommittees
on Laboratory Standards and Procedures,
Follow-up and Treatment, and Education and
Training; (5) workgroup reports on the
second screen study, and carrier screening;
and (6) CDC’s Morbidity and Mortality
Weekly Report on laboratory practices for
genetic testing and newborn screening.
Tentatively, the SACHDNC is expected to
review and/or vote on the following items,
none of which currently involve votes to add
conditions to the RUSP: (1)
Adrenoleukodystrophy—Nomination and
Prioritization Report; (2) Condition Review
Matrix; (3) Second Screen Study from CDC;
and (4) the Morbidity and Mortality Weekly
Report on Good Laboratory Practices for
Biochemical Genetic Testing and Newborn
Screening for Inherited Metabolic Disorder.
Proposed agenda items are subject to
change as priorities dictate. The agenda,
Committee Roster, Charter, presentations,
and meeting materials are located at the
homepage of the Advisory Committee’s Web
site at https://www.hrsa.gov/advisory
committees/mchbadvisory/heritable
disorders.
Public Comments: Members of the public
can submit written comments and/or present
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
oral comments during the public comment
periods of the meeting. All comments,
whether oral or written, are part of the
official Committee record and will be
available for public inspection and copying.
Written comments should be emailed or
received by Thursday, September 6, 2012 to
Debi Sarkar, Maternal and Child Health
Bureau, Health Resources and Services
Administration, Parklawn Building, 5600
Fishers Lane, Room 18A–19, Rockville,
Maryland 20857; email: dsarkar@hrsa.gov.
Comments may also be faxed to 301–480–
1312. Those individuals who want to make
oral comments are required to notify Debi
Sarkar via email or regular mail by 5 p.m.
Eastern Daylight Time, Thursday, September
6, 2012. Notification is required in order to
present oral comments, Oral comments will
be heard on September 13, 2012. All written
and oral comments should contain the name,
address, telephone number, professional or
business affiliation of the author, and topic
of comment. Presentations of oral comments
may be limited depending on the number of
presenters. Individuals who are associated
with groups having similar interests are
requested to combine their comments and
present them through a single representative.
No audiovisual presentations are permitted,
to ensure that all individuals who provided
notification to make oral comments have an
opportunity to present their comments.
Contact Person: Anyone interested in
obtaining other relevant information or
attendees that will require special
accommodations should contact Debi Sarkar,
Maternal and Child Health Bureau, Health
Resources and Services Administration,
Room 18A–19, Parklawn Building, 5600
Fishers Lane, Rockville, Maryland 20857;
telephone: 301–443–1080; email: dsarkar@
hrsa.gov. More information on the Advisory
Committee is available at https://www.hrsa.
gov/advisorycommittees/mchbadvisory/
heritabledisorders.
Dated: August 6, 2012.
Reva Harris,
Acting Director, Division of Policy and
Information Coordination.
[FR Doc. 2012–19654 Filed 8–9–12; 8:45 am]
BILLING CODE 4165–15–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
E:\FR\FM\10AUN1.SGM
10AUN1
47858
Federal Register / Vol. 77, No. 155 / Friday, August 10, 2012 / Notices
mstockstill on DSK4VPTVN1PROD with NOTICES
hereby given of a meeting of the
National Advisory General Medical
Sciences Council.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
General Medical Sciences Council.
Date: September 6–7, 2012.
Closed: September 6, 2012, 8:30 a.m. to 5
p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, Conference Rooms E1 &
E2, 45 Center Drive, Bethesda, MD 20892.
Open: September 7, 2012, 8:30 a.m. to
adjournment.
Agenda: For the discussion of program
policies and issues, opening remarks, report
of the Acting Director, NIGMS, and other
business of the Council.
Place: National Institutes of Health,
Natcher Building, Conference Rooms E1 &
E2, 45 Center Drive, Bethesda, MD 20892.
Contact Person: Ann A. Hagan, Ph.D.,
Associate Director for Extramural Activities,
NIGMS, NIH, DHHS, 45 Center Drive, Room
2AN24H, MSC 6200, Bethesda, MD 20892,
(301) 594–4499, hagana@nigms.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number, and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxis, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit. Information is also available on the
Institute’s/Center’s home page: https://
www.nigms.nih.gov/About/Council/ where
an agenda and any additional information for
the meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
VerDate Mar<15>2010
18:02 Aug 09, 2012
Jkt 226001
Physiology, and Biological Chemistry
Research, National Institutes of Health, HHS)
Dated: August 6, 2012.
Anna P. Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–19695 Filed 8–9–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of The Director, National
Institutes of Health; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the Council
of Councils.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(9)(B), Title 5
U.S.C., as amended. The closed portion
of the meeting is likely to include
disclosure of trade secrets and/or
commercial or confidential financial
information obtained from a person. In
addition, it is likely that premature
disclosure of the matters to be discussed
would significantly frustrate
implementation of a proposed agency
action.
Name of Committee: Council of Councils.
Date: September 5, 2012.
Open: 8:30 a.m. to 1:35 p.m.
Agenda: DPCPSI and NIH Updates,
Comparative Medicine Research Training
Opportunities and Update on Working Group
on Chimpanzees in NIH-Supported Research.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 6, Bethesda, MD 20892.
Closed: 1:35 p.m. to 3:15 p.m.
Agenda: Research Projects Involving
Chimpanzees and Second-Level Review of
Grant Applications.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 6, Bethesda, MD 20892.
Open: 3:15 p.m. to 5 p.m.
Agenda: Updates on Tobacco Control
Regulatory Science & Portfolio Analysis and
Business of the Council.
Place: National Institutes of Health,
Building 31, 31 Center Drive, Conference
Room 6, Bethesda, MD 20892.
Contact Person: Robin Kawazoe, Executive
Secretary, Division of Program Coordination,
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
Planning, and Strategic Initiatives, Office of
The Director, NIH, Building 1, Room 260B,
Bethesda, MD 20892,
KAWAZOER@MAIL.NIH.GOV.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
Information is also available on the Council
of Council’s home page at https://
dpcpsi.nih.gov/council/. Where an agenda
and proposals to be discussed will be posted
before the meeting date.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
Dated: August 3, 2012.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2012–19712 Filed 8–9–12; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended.
The grant applications and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
E:\FR\FM\10AUN1.SGM
10AUN1
]]>Agencies
[Federal Register Volume 77, Number 155 (Friday, August 10, 2012)]
[Notices]
[Pages 47857-47858]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-19695]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of General Medical Sciences; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
[[Page 47858]]
hereby given of a meeting of the National Advisory General Medical
Sciences Council.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory General Medical Sciences
Council.
Date: September 6-7, 2012.
Closed: September 6, 2012, 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Natcher Building,
Conference Rooms E1 & E2, 45 Center Drive, Bethesda, MD 20892.
Open: September 7, 2012, 8:30 a.m. to adjournment.
Agenda: For the discussion of program policies and issues,
opening remarks, report of the Acting Director, NIGMS, and other
business of the Council.
Place: National Institutes of Health, Natcher Building,
Conference Rooms E1 & E2, 45 Center Drive, Bethesda, MD 20892.
Contact Person: Ann A. Hagan, Ph.D., Associate Director for
Extramural Activities, NIGMS, NIH, DHHS, 45 Center Drive, Room
2AN24H, MSC 6200, Bethesda, MD 20892, (301) 594-4499,
hagana@nigms.nih.gov.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number, and when applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxis, hotel, and airport shuttles will be inspected
before being allowed on campus. Visitors will be asked to show one
form of identification (for example, a government-issued photo ID,
driver's license, or passport) and to state the purpose of their
visit. Information is also available on the Institute's/Center's
home page: https://www.nigms.nih.gov/About/Council/ where an agenda
and any additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.859,
Pharmacology, Physiology, and Biological Chemistry Research,
National Institutes of Health, HHS)
Dated: August 6, 2012.
Anna P. Snouffer,
Deputy Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2012-19695 Filed 8-9-12; 8:45 am]
BILLING CODE 4140-01-P
